fenofibrate has been researched along with Arthritis, Rheumatoid in 4 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We prospectively compared the anti-inflammatory and antidyslipidemic effects of fenofibrate and statins in rheumatoid arthritis (RA) patients." | 9.14 | A comparative study of anti-inflammatory and antidyslipidemic effects of fenofibrate and statins on rheumatoid arthritis. ( Goto, M, 2010) |
| "Treatment with fenofibrate resulted in significant decrease in CRP and IL-6 concentrations and improvement in lipid profile." | 6.78 | The effects of fenofibrate on inflammation and cardiovascular markers in patients with active rheumatoid arthritis: a pilot study. ( Kalinovskaya, N; Polovnikova, O; Shirinsky, I; Shirinsky, V, 2013) |
| "We prospectively compared the anti-inflammatory and antidyslipidemic effects of fenofibrate and statins in rheumatoid arthritis (RA) patients." | 5.14 | A comparative study of anti-inflammatory and antidyslipidemic effects of fenofibrate and statins on rheumatoid arthritis. ( Goto, M, 2010) |
| "Treatment with fenofibrate resulted in significant decrease in CRP and IL-6 concentrations and improvement in lipid profile." | 2.78 | The effects of fenofibrate on inflammation and cardiovascular markers in patients with active rheumatoid arthritis: a pilot study. ( Kalinovskaya, N; Polovnikova, O; Shirinsky, I; Shirinsky, V, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hellerstein, M | 1 |
| Turner, S | 1 |
| Goto, M | 1 |
| Shirinsky, I | 1 |
| Polovnikova, O | 1 |
| Kalinovskaya, N | 1 |
| Shirinsky, V | 1 |
| Okamoto, H | 1 |
| Kamatani, N | 1 |
1 review available for fenofibrate and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Reverse cholesterol transport fluxes.
Topics: Arthritis, Rheumatoid; Azetidines; Biological Transport; Cholesterol; Ezetimibe; Fenofibrate; Humans | 2014 |
2 trials available for fenofibrate and Arthritis, Rheumatoid
| Article | Year |
|---|---|
A comparative study of anti-inflammatory and antidyslipidemic effects of fenofibrate and statins on rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Dyslipidemias; Female; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA R | 2010 |
The effects of fenofibrate on inflammation and cardiovascular markers in patients with active rheumatoid arthritis: a pilot study.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; C-Reactive Protein; Drug Therapy, Combinati | 2013 |
1 other study available for fenofibrate and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Successful treatment with fenofibrate, a peroxisome proliferator activated receptor alpha ligand, for a patient with rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Fenofibrate; Humans; Ligands; Receptors, | 2004 |